Publication
Pragmatic Screening for Sarcopenia in Non-Small Cell Lung Cancer: Development and Internal Validation of a Prospective Risk Model Integrating T12 CT Indices and Routine Clinical Variables.
Zhuorui You, Wei Dai, Hechen Shen, Xing Wei, Cheng Lei, Jia Liao, Jieming Cao, Minxian Li, Jia Wang, Mengqi Shao, Gang Li
Cancer medicineOct 1, 2026PMID 42791661doi:10.1002/cam4.72230 PMC13615309Journal ArticlepubmedProvenance
- Source
- PubMed
- Retrieved
- Oct 1, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20261001-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
BACKGROUND: Sarcopenia or low muscle mass is common in non-small cell lung cancer and predicts poorer outcomes, but its assessment typically relies on CT-based skeletal muscle index at the L3 vertebral level. Standard chest CTs often omit the L3 level, leaving many patients without a…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Lung Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available
No curated evidence item cites this publication.